In Brief: Hoechst Marion Roussel

Executive Summary

Hoechst Marion Roussel: Requests FTC approval to license generic dicyclomine for treatment of irritable bowel syndrome to DuPont Merck subsidiary Endo Labs to fulfill the consent decree Marion Merrell Dow signed with FTC for final approval of its Rugby acquisition in May 1994, FTC announces Oct. 6. Under the consent decree, MMD agreed that within 12 months of the final date of the consent decree it would license dicyclomine formulation and product technology to a third party and contract manufacture of dicyclomine with a third party until it gains FDA approval for its own product ("The Pink Sheet" June 27, 1994, T&G-12). Hoechst's request will be subject to public comment until Nov. 6...